Una pequeña molécula dirigida a la síntesis de la translección mutagénica mejora la quimioterapia
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Los investigadores desarrollaron un nuevo inhibidor de moléculas pequeñas, JH-RE-06, para atacar la síntesis de translesión mutagénica (TLS). Este avance mejora la eficacia de la quimioterapia al bloquear la resistencia a los medicamentos y reducir las mutaciones inducidas por el tratamiento.
Área De La Ciencia
- En el campo de la oncología
- Biología molecular
- Descubrimiento de drogas
Sus Antecedentes
- La resistencia a los medicamentos y las neoplasias secundarias limitan la eficacia de la quimioterapia.
- La síntesis de la translesión mutagénica (TLS) promueve la quimiorresistencia y las mutaciones inducidas por el tratamiento.
- Dirigirse a TLS es una estrategia prometedora para mejorar la quimioterapia, pero los inhibidores específicos son difíciles de desarrollar.
Objetivo Del Estudio
- Descubrir y caracterizar un nuevo inhibidor de moléculas pequeñas dirigido a TLS mutagénico.
- Evaluar la eficacia del inhibidor en modelos preclínicos de cáncer.
Principales Métodos
- Descubrimiento de JH-RE-06, un inhibidor de moléculas pequeñas de TLS mutagénico.
- Investigación del mecanismo de acción de JH-RE-06, centrada en la interacción entre REV1 y POL ζ.
- Evaluación de la capacidad del JH-RE-06 para inhibir el TLS mutagénico in vitro.
- Evaluación del efecto de JH-RE-06 en la toxicidad inducida por el cisplatino en las líneas celulares.
- Prueba de la eficacia de JH-RE-06 en combinación con cisplatino en un modelo de ratón con melanoma humano trasplantado.
Principales Resultados
- JH-RE-06 interrumpe el TLS mutagénico impidiendo el reclutamiento de POL ζ mutagénico.
- El inhibidor se une a REV1, induciendo la dimerización y bloqueando la interacción REV1-REV7.
- JH-RE-06 inhibe el TLS mutagénico y potencia la toxicidad inducida por el cisplatino en líneas celulares humanas y de ratón.
- La administración combinada de JH-RE-06 y cisplatino suprimió el crecimiento del melanoma xenograft en ratones.
Conclusiones
- JH-RE-06 es un potente inhibidor del TLS mutagénico con eficacia in vivo.
- Este estudio establece un marco para el desarrollo de inhibidores de TLS como nuevos adyuvantes de quimioterapia.
- La orientación de TLS ofrece una estrategia prometedora para superar la quimiorresistencia y mejorar los resultados del tratamiento del cáncer.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Overview
Dehydration synthesis (also called a condensation reaction) is the chemical process in which two molecules covalently link together to form a new molecule, along with the release of a water molecule. Many physiologically important compounds form by dehydration synthesis reactions, such as complex carbohydrates, proteins, DNA, and RNA.
Synthesis of carbohydrates
Sugar molecules are covalently linked together by dehydration synthesis. During the reaction, the hydroxyl (-OH) group from...
Synthesis and decomposition are two types of redox reactions. Synthesis means to make something, whereas decomposition means to break something. The reactions are accompanied by chemical and energy changes.
Synthesis Reactions
Synthesis reactions are also called combination reactions. It is a reaction in which two or more substances combine to form a complex substance. Synthesis reactions are generally represented as: A + B → AB or A + B → C. The formation of nitrogen dioxide...
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Atoms and Molecules
Everything in the universe is made up of matter, and matter is composed of a combination of elements. An atom is the smallest unit of an element that retains all properties of the element. For example, a silver coin is made up of silver atoms, and each silver atom retains the unique properties of the element — silver.
Elements are pure substances consisting of identical atoms that cannot be broken down into simpler substances by chemical changes. Atomic...